微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 51.4% | -11.39% | 5.52% | 73/159 | -1.59% | 海创药业 | 99.57% | 行业排名> |
| 2025-06-30 | 48.71% | -11.91% | 10.84% | 76/159 | 15.28% | 海创药业 | 99.52% | 行业排名> |
| 2025-03-31 | 43.95% | -23.13% | -23.59% | 86/159 | 32.3% | 艾力斯 | 96.74% | 行业排名> |
| 2024-12-31 | 57.51% | 3.08% | -0.85% | 56/159 | 51.78% | 首药控股 | 98.96% | 行业排名> |
| 2024-09-30 | 58% | -0.99% | 4.9% | 58/159 | 22.81% | 迪哲医药 | 97.73% | 行业排名> |
| 2024-06-30 | 55.3% | -1.3% | -3.27% | 67/159 | 33.25% | 百利天恒 | 97.99% | 行业排名> |
| 2024-03-31 | 57.17% | -2.91% | 2.46% | 57/159 | 51.56% | 百利天恒 | 98.92% | 行业排名> |
| 2023-12-31 | 55.79% | -11.45% | -4.76% | 68/159 | 51.39% | 迈威生物 | 98.93% | 行业排名> |
| 2023-09-30 | 58.58% | -6.27% | 4.56% | 60/159 | 32.56% | 迈威生物 | 99.59% | 行业排名> |
| 2023-06-30 | 56.03% | -9.57% | -4.85% | 65/159 | 38.45% | 迈威生物 | 99.8% | 行业排名> |
| 2023-03-31 | 58.88% | -7.39% | -6.56% | 56/159 | 52.78% | 迈威生物 | 99.46% | 行业排名> |
| 2022-12-31 | 63.01% | 12.07% | 0.81% | 53/159 | 53.66% | 迈威生物 | 99.75% | 行业排名> |
| 2022-09-30 | 62.5% | 8.03% | 0.89% | 52/159 | 6.2% | 迈威生物 | 99.67% | 行业排名> |
| 2022-06-30 | 61.95% | 9.7% | -2.56% | 55/159 | 21.37% | 迈威生物 | 99.44% | 行业排名> |
| 2022-03-31 | 63.58% | 17.23% | 13.07% | 48/159 | 54.28% | 迈威生物 | 98.57% | 行业排名> |
| 2021-12-31 | 56.23% | 2.37% | -2.81% | 71/159 | 55.1% | 首药控股 | 99.93% | 行业排名> |
| 2021-09-30 | 57.85% | -0.54% | 2.45% | 58/159 | 46.78% | 艾力斯 | 99.41% | 行业排名> |
| 2021-06-30 | 56.47% | -4.54% | 4.14% | 67/159 | 47.23% | 艾力斯 | 98.7% | 行业排名> |
| 2021-03-31 | 54.23% | -13.12% | -1.27% | 67/159 | 53.99% | 艾力斯 | 99.4% | 行业排名> |
| 2020-12-31 | 54.93% | -14.24% | -5.58% | 70/159 | -145.9% | 首药控股 | 99.94% | 行业排名> |
| 2020-09-30 | 58.17% | -6.23% | -1.67% | 55/159 | 56.36% | 泽璟制药 | 99.96% | 行业排名> |
| 2020-06-30 | 59.16% | 2% | -5.23% | 54/159 | 54.11% | 微芯生物 | 95.14% | 行业排名> |
| 2020-03-31 | 62.42% | -0.87% | -2.53% | 43/159 | 55.23% | 多瑞医药 | 95.59% | 行业排名> |
| 2019-12-31 | 64.04% | 9.56% | 3.24% | 47/159 | -1222.98% | 微芯生物 | 95.81% | 行业排名> |
| 2019-09-30 | 62.03% | 2% | -1.48% | 42/159 | 55.21% | 微芯生物 | 96.09% | 行业排名> |
| 2019-03-31 | 62.97% | 2% | 7.72% | 37/159 | 51.05% | 微芯生物 | 96.11% | 行业排名> |
| 2018-12-31 | 58.45% | -0.8% | -0.8% | 57/159 | -208.09% | 微芯生物 | 95.5% | 行业排名> |
| 2017-12-31 | 58.93% | 2.17% | 2.17% | 44/159 | 52.32% | 微芯生物 | 96.27% | 行业排名> |
| 2016-12-31 | 57.67% | 2% | 2% | 35/159 | 48.19% | 贝达药业 | 95.47% | 行业排名> |